- Home
- JMIA vs ATAI Comparison
JMIA vs ATAI Comparison
Compare JMIA & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JMIA | ATAI |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | JMIA | ATAI |
|---|---|---|
| Price | $7.57 | $3.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $16.75 | $15.57 |
| AVG Volume (30 Days) | 2.2M | ★ 4.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,000.00 |
| Revenue This Year | $28.66 | N/A |
| Revenue Next Year | $18.10 | $285.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.60 | $1.15 |
| 52 Week High | $14.72 | $6.73 |
Technical Indicators
Market Signals| Indicator | JMIA | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 30.55 | 39.75 |
| Support Level | $6.86 | $1.29 |
| Resistance Level | $13.26 | $4.40 |
| Average True Range (ATR) | 0.40 | 0.28 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 16.47 | 4.57 |
Price Performance
Historical ComparisonAbout JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.